查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701263

结核病诊断市场规模、份额、趋势分析报告（按类型、最终用途、地区、细分市场预测），2025-2030 年

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

结核病诊断市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球结核病诊断市场规模预计到2030年将达到31.8亿美元，2025年至2030年期间的复合年增长率为5.8%。

干扰素-γ释放试验（IGRA）、血清学技术和核酸检测等先进诊断方法的出现，使得诊断剂的利用率提高了。此外，抗原检测等即时诊断（POC）技术也提高了结核病的诊断率。

这些先进的方法，包括 POC 诊断，价格实惠、准确、方便且能快速提供结果。此外，结核病负担的增加是市场成长的主要动力。根据世界卫生组织（WHO）的估计，2014年全球结核病病例数约为960万人。如此高的发病率促使政府、医疗保健组织、研究机构和市场相关人员纷纷采取行动遏制感染疾病。

提高高负担地区的筛检率、负担得起的诊断方法、先进的调查方法、快速的临床决策和降低死亡率是发展的重点。这些努力的最终结果是预防和治疗诊断率的提高。这导致诊断测试的需求激增，扩大了结核病诊断市场。

结核病诊断市场报告重点

  • 受结核病患者病率上升的推动，潜在感染检测领域（皮肤测试和 IGRA）将在 2024 年占据 40.59% 的市场份额，占据市场主导地位。
  • 预计药物抗药性（DST）将在预测期内实现最快的复合年增长率。药敏试验评估结核菌对各种抗生素的敏感性，并确定哪些药物对治疗疾病有效。
  • 2024 年，诊断实验室部门占据了最大的收入份额，并成为结核病诊断市场的驱动力。
  • 受医疗机构结核病检测率上升的推动，医院和诊所部门预计将经历强劲增长。
  • 预计亚太地区结核病诊断市场将在 2024 年占据市场主导地位，收益占有率为 37.18%，预计在预测期内将以最快的速度成长。

目录

第一章调查方法与范围

第二章执行摘要

3. 结核病诊断市场变数、趋势和范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 结核病诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析
    • 案例研究

第四章结核病诊断市场：按类型估计和趋势分析

  • 2024 年及 2030 年各类型市场占有率
  • 细分仪表板
  • 全球结核病诊断市场：按类型展望
  • 检测潜伏感染（皮肤检测和IGRA）
  • 噬菌体试验
  • 抗药性检测（DST）
  • 核酸检测
  • 放射学方法
  • 细胞激素检测试验
  • 其他的

第五章结核病诊断市场：依最终用途的估计和趋势分析

  • 2024 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 全球结核病诊断市场：最终用途展望
  • 诊断实验室
  • 医院和诊所
  • 其他的

6. 结核病诊断市场：区域估计和趋势分析（按产品、类型和最终用途）

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018年至2030年市场规模与预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 2024年主要企业的市场占有率/地位分析
  • 公司简介
    • Abbott
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • BD
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Cepheid
    • DiaSorin SpA
    • Hain Lifescience GmbH
    • Oxford Immunotec
Product Code: GVR-1-68038-098-9

Tuberculosis Diagnostics Market Growth & Trends:

The global tuberculosis diagnostics market size is expected to reach USD 3.18 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Tuberculosis Diagnostics Market Report Highlights:

  • The latent infection detection segment (Skin Test & IGRA) led the market in 2024 with a 40.59% share, driven by the increasing prevalence of tuberculosis.
  • Drug Resistance (DST) is projected to achieve the fastest CAGR during the forecast period. DST evaluates the susceptibility of Mycobacterium tuberculosis to various antibiotics, identifying which drugs are effective for treatment.
  • In 2024, the diagnostic laboratories segment dominated the TB diagnostics market with the largest revenue share, driven by initiatives to enhance patient outcomes through accessible, retail-level diagnostic services.
  • The hospitals and clinics segment is poised for significant growth, driven by increasing TB testing rates in healthcare settings.
  • The tuberculosis diagnostics market in Asia Pacific dominated the market with revenue share of 37.18% in 2024 and is expected to witness the fastest growth over the forecast period.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market opportunities analysis
  • 3.2. Tuberculosis Diagnostics Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis
    • 3.2.4. Case Studies

Chapter 4. Tuberculosis Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Tuberculosis Diagnostics Market by Type Outlook
  • 4.4. Detection of Latent Infection (Skin Test & IGRA)
    • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Phage Assay
    • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. Detection of Drug Resistance (DST)
    • 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Nucleic Acid Testing
    • 4.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Radiographic Method
    • 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Cytokine Detection Assay
    • 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Tuberculosis Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Tuberculosis Diagnostics Market by End Use Outlook
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. Hospitals & Clinics
    • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share/position analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Abbott
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Technology Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. QIAGEN
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Technology Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Thermo Fisher Scientific Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Technology Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. BD
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Technology Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. F. Hoffmann-La Roche AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Technology Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Hologic, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Technology Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Cepheid
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Technology Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. DiaSorin S.p.A.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Technology Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Hain Lifescience GmbH
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Technology Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Oxford Immunotec
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Technology Type benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 4 North America Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 8 Canada Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 10 Mexico Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 12 Europe Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 13 UK Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 14 UK Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Germany Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 16 Germany Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 17 France Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 18 France Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 20 Italy Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 22 Spain Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 24 Denmark Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 26 Sweden Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 28 Norway Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 Japan Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 32 Japan Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 33 China Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 34 China Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 India Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 36 India Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 38 Australia Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 45 Brazil Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Argentina Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 48 Argentina Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 49 MEA Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 50 MEA Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 South Africa Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 52 South Africa Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 UAE Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 56 UAE Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 57 Kuwait Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 58 Kuwait Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tuberculosis Diagnostics market outlook
  • Fig. 9 Tuberculosis Diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tuberculosis Diagnostics market driver impact
  • Fig. 15 Tuberculosis Diagnostics market restraint impact
  • Fig. 16 Tuberculosis Diagnostics market strategic initiatives analysis
  • Fig. 17 Tuberculosis Diagnostics market: Type analysis
  • Fig. 18 Tuberculosis Diagnostics market: Type outlook and key takeaways
  • Fig. 19 Detection of Latent Infection (Skin Test & IGRA) market estimates and forecast, 2018 - 2030
  • Fig. 20 Phage assay market estimates and forecast, 2018 - 2030
  • Fig. 21 Detection of Drug Resistance (DST) market estimates and forecast, 2018 - 2030
  • Fig. 22 Nucleic Acid Testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Radiographic method market estimates and forecast, 2018 - 2030
  • Fig. 24 Cytokine detection assay market estimates and forecast, 2018 - 2030
  • Fig. 25 Others market estimates and forecast, 2018 - 2030
  • Fig. 26 Lumbar puncture market estimates and forecast, 2018 - 2030
  • Fig. 27 Nerve conduction studies market estimates and forecast, 2018 - 2030
  • Fig. 28 Electromyography market estimates and forecast, 2018 - 2030
  • Fig. 29 Others market estimates and forecast, 2018 - 2030
  • Fig. 30 Tuberculosis Diagnostics market: End use movement analysis
  • Fig. 31 Tuberculosis Diagnostics market: End use outlook and key takeaways
  • Fig. 32 Diagnostic laboratories market estimates and forecast, 2018 - 2030
  • Fig. 33 Hospitals & clinics market estimates and forecast, 2018 - 2030
  • Fig. 34 Others market estimates and forecast, 2018 - 2030
  • Fig. 35 Global Tuberculosis Diagnostics market: Regional movement analysis
  • Fig. 36 Global Tuberculosis Diagnostics market: Regional outlook and key takeaways
  • Fig. 37 Global Tuberculosis Diagnostics market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America market estimates and forecasts, 2018 - 2030
  • Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 62 China market estimates and forecasts, 2018 - 2030
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 64 India market estimates and forecasts, 2018 - 2030
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 72 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 74 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Tuberculosis Diagnostics market
  • Fig. 77 Key Company Categorization
  • Fig. 78 Company Market Share/Position Analysis, 2024
  • Fig. 79 Strategic Framework